COVID-19 Nsp13 Helicase Analysis: Assessment of Unwinding SARS-CoV-2 Mutagenic RNA Secondary Structures and Pharmacological Modulation in a Preclinical Model

NIH Pandemic-Era Grants

Pandemic Era Grants

2024

↗ Live URL (may be dead)

Document text

Principal Investigator: Robert  Brosh
Organization: NATIONAL INSTITUTE ON AGING
Fiscal Year: 2024
Award: $352,051
Funding agency: National Institute on Aging

Point mutations in the SARS-CoV-2 genome have potential consequences for the novel coronavirus life cycle, leading to alterations in its ability to replicate or transcribe its genome with an impact on transmission and virulence. Therefore, characterization of the cis- and trans-activating factors responsible for genetic variation will lead to a better understanding of the novel coronavirus virulency. Mapping point mutations in secondary RNA structures of the SARS-CoV-2 genome will be performed to determine their enrichment and delineate if coronavirus nucleic acid structure plays a role in mutagenesis. Among the key players in SARS-CoV-2 replication predicted to act upon RNA secondary structures formed by G4 and SL sequence motifs in the coronavirus genome is the virally encoded RNA helicase Nsp13. Nsp13, in complex with the Nsp12 RNA-dependent RNA polymerase, processivity factors (Nsp7, Nsp8), and proofreading exonuclease (Nsp14) potentially coordinate with host cell factors in a still not well understood mechanism to replicate the coronavirus RNA genome. Characterizing the molecular functions of Nsp13 is important to understand its role in the mechanism of coronavirus genome duplication and transcription. Nsp13, like other proteins implicated in coronavirus genome replication, may be a useful target for pharmacological modulation as an anti-viral strategy to combat the virus and potentially treat symptoms of COVID-19 in infected individuals. The proposed studies will employ a SARS-CoV-2 Nsp13 helicase targeted library to assess replication of the mouse hepatitis virus (MHV), an excellent model for SARS-CoV-2.

Terms: <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><Biochemical><COVID-19><COVID-19 genome><COVID-19 virus><COVID-19 virus genome><COVID19 genome><COVID19 virus><COVID19 virus genome><CV-19><Cell Body><Cells><CoV emergence><CoV-2><CoV2><Complex><Coronaviridae><Coronavirus><Coronavirus Infectious Disease 2019><DNA Helicases><DNA Unwinding Proteins><DNA unwinding enzyme><EC 2.7.7.48><Exonuclease><G-Quadruplex><G-Quadruplexes DNA><G-Quartet Structures><G-Quartets><G-Tetrads><G4-DNA><Gene Transcription><Genetic Alteration><Genetic Change><Genetic Diversity><Genetic Transcription><Genetic Variation><Genetic defect><Genetics-Mutagenesis><Genome><Genomics><In Vitro><Individual><Libraries><Life Cycle><Life Cycle Stages><Maps><Mice><Mice Mammals><Modeling><Molecular><Mouse Hepatitis Coronavirus><Mouse Hepatitis Virus><Murine><Murine Gastroenteritis Virus><Murine hepatitis virus><Mus><Mutagenesis><Mutagenesis Molecular Biology><Mutation><Non-Polyadenylated RNA><Point Mutation><Pre-Clinical Model><Preclinical Models><Proteins><RNA><RNA Expression><RNA Gene Products><RNA Helicase><RNA Replicase><RNA-Dependent RNA Polymerase><RNA-Directed RNA Polymerase><Ribonucleic Acid><Role><SARS corona virus 2><SARS-CO-V2><SARS-COVID-2><SARS-CoV-2><SARS-CoV-2 genome><SARS-CoV2><SARS-CoV2 genome><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome related corona virus 2><Structure><Transcription><Transmission><Viral><Virulence><Virulent><Virus><Wuhan coronavirus><combat><corona virus><corona virus emergence><coronavirus disease 2019><coronavirus disease 2019 genome><coronavirus disease 2019 virus><coronavirus disease 2019 virus genome><coronavirus disease-19><coronavirus disease-19 virus><coronavirus emergence><coronavirus infectious disease-19><emergent CoV><emergent corona virus><emergent coronavirus><emerging CoV><emerging corona virus><emerging coronavirus><genome mutation><hCoV19><helicase><in vivo><inhibitor><life course><murine hepatitis coronavirus><nCoV><nCoV2><new CoV><new corona virus><new coronavirus><novel CoV><novel corona virus><novel coronavirus><nucleic acid structure><pharmacologic><severe acute respiratory syndrome coronavirus 2 genome><social role><stem><symptom treatment><symptomatic treatment><transmission process><treat symptom>